SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001102624-16-003292
Filing Date
2016-08-15
Accepted
2016-08-15 16:10:40
Documents
46
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 AEOLUS PHARMACEUTICALS, INC. 10-Q aeolus10q.htm 10-Q 568909
2 EXHIBIT 31.1 exh31_1.htm EX-31.1 11315
3 EXHIBIT 31.2 exh31_2.htm EX-31.2 11696
4 EXHIBIT 32.1 exh32_1.htm EX-32.1 6540
  Complete submission text file 0001102624-16-003292.txt   3085292

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aols-20160630.xml EX-101.INS 653853
6 XBRL TAXONOMY EXTENSION SCHEMA aols-20160630.xsd EX-101.SCH 36473
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aols-20160630_cal.xml EX-101.CAL 27784
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aols-20160630_def.xml EX-101.DEF 88589
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aols-20160630_lab.xml EX-101.LAB 247253
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aols-20160630_pre.xml EX-101.PRE 174057
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

IRS No.: 561953785 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-50481 | Film No.: 161832773
SIC: 2834 Pharmaceutical Preparations